23 Jul 2008 07:30
ο»Ώ
23rd July 2008
Renishaw plc and subsidiary undertakings
Preliminary announcement of results for the year ended 30th June 2008
HIGHLIGHTS
Record results - revenue, profit and cash flow all increased
Revenue growth in all geographic territories
Engineering costs, including research and development, increasedΒ by 14%
Operating marginΒ increasedΒ to 18.6% (2007 16.4%)
Earnings per share increasedΒ by 28%
Dividend increasedΒ by 11%
CONSOLIDATED INCOME STATEMENT
|
2008 |
2007 |
||
|
Β£'000 |
Β£'000 |
||
|
Revenue |
201,157 |
180,883 |
|
|
Cost of sales |
(106,759) |
(97,899)Β |
|
|
Gross profit |
94,398 |
82,984 |
|
|
Distribution costs |
(35,694) |
(32,911)Β |
|
|
Administration costs |
(21,369) |
(20,408)Β |
|
|
Operating profit before pension curtailment credit |
37,335 |
29,665 |
|
|
Pension curtailment credit |
1,344 |
19,460 |
|
|
Operating profit |
38,679 |
49,125 |
|
|
Financial income |
9,194 |
8,180 |
|
|
Financial expenses |
(5,070) |
(5,237) |
|
|
Share of profits of associates |
256 |
64 |
|
|
Profit before tax |
43,059 |
52,132 |
|
|
Income tax expense |
(8,443) |
(11,981) |
|
|
Profit for the year |
34,616 |
40,151 |
|
|
Profit attributable to equity shareholders |
34,716 |
40,151 |
|
|
Minority interest |
(100) |
- |
|
|
34,616 |
40,151 |
*************************
|
Adjusted earnings per share (excluding pension curtailment credit) |
45.9p |
35.9p |
|
|
Earnings per share (basic and diluted) |
47.6p |
55.2p |
|
|
Dividend per share arising in respect of the year |
25.39p |
22.87p |
Β Β
CONSOLIDATED BALANCE SHEET
|
at 30thΒ June |
2008 Β£'000 |
2007 Β£'000 |
|
|
|
|
||
|
Assets |
|
|
|
|
Property, plant and equipment |
68,766 |
69,460 |
|
|
Intangible assets |
19,085 |
13,811 |
|
|
InvestmentsΒ in associates |
6,788 |
6,972 |
|
|
Deferred tax assets |
10,025 |
4,733 |
|
|
Employee benefits |
- |
5,562 |
|
|
Total non-current assets |
104,664 |
100,538 |
|
|
Current assets |
|||
|
Inventories |
34,220Β |
36,178Β |
|
|
Trade receivables |
Β 42,803Β |
37,880Β |
|
|
Current tax |
Β 490Β |
323Β |
|
|
Other receivables |
5,036 |
6,482 |
|
|
Cash and cash equivalents |
38,183 |
20,761 |
|
|
Total current assets |
120,732 |
101,624 |
|
|
Β |
Β |
||
|
Current liabilities |
|||
|
Trade payables |
12,691 |
11,223 |
|
|
Current tax |
2,178 |
1,315 |
|
|
Provisions |
824 |
693 |
|
|
Other payables |
15,653 |
8,779 |
|
|
Total current liabilities |
31,346 |
22,010 |
|
|
Net current assets |
89,386 |
79,614 |
|
|
Liabilities |
|||
|
Employee benefits |
11,055 |
- |
|
|
Deferred tax liabilities |
12,382 |
12,152 |
|
|
Other payables |
3,968 |
- |
|
|
Total non-current liabilities |
27,405 |
12,152 |
|
|
Total assets less total liabilities |
166,645 |
168,000 |
|
|
Equity |
|||
|
ShareΒ capital |
14,558 |
14,558 |
|
|
Share premium |
42 |
42 |
|
|
Currency translation reserve |
1,574 |
(210) |
|
|
Cash flow hedging reserve |
(4,252) |
1,845 |
|
|
Retained earnings |
154,403 |
151,765 |
|
|
Total equityΒ attributable to shareholders |
166,325 |
168,000 |
|
|
Minority interest |
320 |
- |
|
|
166,645 |
168,000 |
Β Β
CONSOLIDATED STATEMENT OF CASH FLOW
|
2008 Β£'000 |
2007 Β£'000 |
||
|
Cash flows from operating activities |
|||
|
Profit for the year |
Β 34,616Β |
40,151 |
|
|
Adjustments for: |
|||
|
Amortisation of development costs |
2,743 |
2,038 |
|
|
Amortisation of other intangibles |
1,512 |
1,286 |
|
|
Depreciation |
8,061 |
7,874 |
|
|
Profit on sale of property, plant and equipment |
(1,042) |
(25) |
|
|
Share of profits from associates |
(256) |
(64) |
|
|
Pension curtailment credit |
(1,344) |
(19,460) |
|
|
Financial income |
(9,194) |
(8,180) |
|
|
Financial expenses |
5,070 |
5,237 |
|
|
Tax expense |
8,443 |
11,981 |
|
|
13,993 |
687 |
||
|
Decrease/(increase)Β in inventories |
1,958 |
(7,819) |
|
|
Increase in trade and other receivables |
(2,733) |
(2,936) |
|
|
Increase/(decrease)Β in trade and other payables |
5,916 |
(336) |
|
|
Difference between pension service costΒ and contributions |
(58) |
(266) |
|
|
Increase/(decrease)Β in provisions |
131 |
(100) |
|
|
5,214 |
(11,457) |
||
|
Income taxes paid |
(6,902) |
(7,021) |
|
|
Cash flows from operating activities |
46,921 |
22,360 |
|
|
Investing activities |
|||
|
Purchase ofΒ property, plant and equipment |
(5,133) |
(10,037) |
|
|
Development costs capitalised |
(5,497) |
(3,624) |
|
|
Purchase of other intangibles |
(1,319) |
(865) |
|
|
Purchase of business |
(482) |
- |
|
|
Investment in associate |
- |
(6,110) |
|
|
SaleΒ of property, plant and equipment |
1,421 |
187 |
|
|
Interest received |
1,743 |
1,710 |
|
|
DividendΒ receivedΒ from associate |
80 |
- |
|
|
Cash flows from investing activities |
(9,187)Β |
(18,739) |
|
|
Financing activities |
|||
|
Interest paid |
(141)Β |
(297)Β |
|
|
Dividends paid |
(17,164)Β |
(16,101)Β |
|
|
Cash flows from financing activities |
(17,305) |
(16,398) |
|
|
NetΒ increase/(decrease)Β in cash and cash equivalents |
20,429 |
(12,777) |
|
|
Cash and cash equivalents at beginning of the year |
20,761Β |
30,728 |
|
|
Effect of exchange rate fluctuations on cash held |
(3,007) |
2,810 |
|
|
Β |
|||
|
Cash and cash equivalents at end of the year |
38,183Β |
20,761 |
Β Β
CONSOLIDATED STATEMENT OF RECOGNISED INCOME AND EXPENSE
|
2008 Β£'000 |
2007 Β£'000 |
||
|
Β |
|
||
|
Foreign exchange translation differences |
1,784 |
(475) |
|
|
ActuarialΒ (loss)/gainΒ in the pension schemes |
(20,541)Β |
3,144 |
|
|
Effective portion of changes in fair value of cash flow hedges |
(8,469) |
(304) |
|
|
Deferred tax on income and expense recognised in equityΒ |
7,999 |
(1,151) |
|
|
|
|||
|
(Expense)/incomeΒ recognised directly in equity |
(19,227) |
1,214 |
|
|
|
|||
|
Profit for the year |
34,716 |
40,151 |
|
|
Total recognised income and expense for the year |
15,489 |
41,365 |
|
REVENUE ANALYSIS
|
2008 Β£'000 |
2008Β at 2007Β exchange rates Β£'000 |
2007 Β£'000 |
|||
|
ContinentalΒ Europe |
77,219 |
73,686 |
67,196 |
||
|
Far East, includingΒ JapanΒ &Β Australia |
59,536 |
58,716 |
50,736 |
||
|
North & South America |
46,644 |
47,413 |
46,160 |
||
|
Rest of World |
5,738 |
5,701 |
5,002 |
||
|
UKΒ andΒ Ireland |
12,020 |
12,020 |
11,789 |
||
|
Total Group revenue |
201,157 |
197,536 |
180,883 |
*************************
NOTES:
The Chairman's statement to be included in the 2008Β Annual report and financial statements:
I am delighted toΒ announce recordΒ resultsΒ for the financial year to 30thΒ June 2008.
RevenueΒ
RevenueΒ growth has accelerated since the half year resulting in an overall increase of 11% to Β£201.2m (2007 Β£180.9m)Β representing growth of 9% at constant exchange rates. We have experienced growth across all geographical markets, in particular theΒ FarΒ East andΒ EuropeΒ andΒ there wasΒ significantΒ progress in our laser calibration,Β machine tool and encoder product lines.
Profit
Operating profit,Β excludingΒ pension curtailment credits in Ireland in 2008 and in the UK in 2007,Β increased by 28% toΒ Β£37.3m (2007 Β£29.7m), reflecting in part Β£1.4m of additional profit due to favourable exchange rates.Β Profit before tax,Β excludingΒ pension curtailment credits, increased by 28% toΒ Β£41.7m (2007 Β£32.7m), resulting inΒ adjustedΒ earnings per shareΒ up 28% to 45.9p (2007Β 35.9p).
Sales andΒ marketing
Renishaw increased its market penetration and market offering. We continue to focus onΒ existing markets,Β customersΒ andΒ new applicationsΒ forΒ ourΒ ever-increasingΒ product range. Our overseas marketing and sales network has been further strengthened during the year, particularly in the Far East,Β IndiaΒ andΒ Brazil.Β
Renishaw's 5-axis scanning and measuring product Renscan5 and REVOβ’Β isΒ now being widely acceptedΒ for new sales and also increasingly for the substantial retrofit market,Β reflecting the significant improvements available to customers on throughput and productivity. The new laser interferometerΒ XL-80Β and XC-80 compensator productsΒ within the laser and calibration market have alsoΒ been veryΒ warmly welcomed.
Manufacturing
During the year we have completed the introduction inΒ bothΒ theΒ UKΒ andΒ IndiaΒ of our new manufacturing Enterprise Resource PlanningΒ (ERP) systemΒ whichΒ will give rise toΒ improved manufacturing efficiencies, from the ordering of goods from suppliers to theΒ productionΒ of finished products.Β
In addition a groupwide initiative to review and implement changes to inventory management policies was established. This has resulted in group inventory being reduced by Β£2.0m at 17% of sales (2007 20%), despite the increase in turnover; at the same time the level of finished stock has increased by 12%, maintaining and improving our ability to respond to customer demands. The effects of this initiative should continue to be evident in the current financial year. InΒ IndiaΒ our production facility in Pune is to be further enlarged, building on its success in improved quality control, cost reduction and increasing volumes.
ResearchΒ andΒ development
Research and development remains at the core of Renishaw's business and new and updated products continue to increase our product range and help maintain our market position. Total engineering expenditure including research and development increased by 14% to Β£35.4m (2007 Β£31.1m) prior to the capitalisation of development costs (net of amortisation) of Β£2.8m (2007 Β£1.6m) giving a net profit and loss charge of Β£32.6m (2007 Β£29.5m).
A number of new products have been introduced during the year including:
Two new high-accuracy strain gauge touch trigger probes for machine tool applications
A contact sensing probe for articulating arm measuring machines
Neuro|inspireβ’Β software and neuro|guideβ’Β devices for neurosurgical procedures
New CAD software for the design of dental crowns and bridges
New interfaces for our laser scales and encoders
New and improved range of angle and linear encoders
New low-cost servo controller and handset for CMMs
Thermally controlled module rack for scanning probes
The application of Renishaw technology to markets outside traditional engineering continues to challenge and excite the Company. The development of precision functional neurosurgery is the latest to offer significant potential in the medium-term to add to our growing interest in advancing dental technology.
Patents
Renishaw invests heavily in the research and development of new products and in protecting intellectual property rights by way of patents and proprietary processes. As a matter of policy therefore, Renishaw takes action for alleged patent infringements where appropriate. In June 2008 we announced that Renishaw has commenced legal proceedings in theΒ USΒ in the Northern District of Illinois against Tesa SA and Hexagon Metrology Inc, each part of the Hexagon Metrology Group ofΒ HexagonΒ AB, a Swedish company. It is considered that the litigation could take several years to reach a final decision.
Balance sheet
Operating cash flow more than doubled to Β£46.9m (2007 Β£22.4m) reflecting both improved profitability and management of working capital.Β Capital expenditure was Β£5.2m, compared with Β£9.7m. At the year endΒ group net cash balancesΒ increased toΒ Β£38.2m (2007 Β£20.8m), providing a sound basis for future investment opportunities.Β
Employees
This year has involved a great deal of hard workΒ and commitmentΒ by ourΒ employeesΒ who, at the year end, numbered 2,151 (2007 2,154).Β I am grateful to them all for their individual contribution which has led to this successful year.
I am also pleased to welcome Bill Whiteley as a new non-executive director. I am sure his experience at Rotork plc where he was CEO during a period of substantial growth will be invaluable to Renishaw.
Prospects and dividend
2008 was a very successful year with record results. The Group continues to expand its international presence and the flow of new products entering the market. These provide the platforms to maintain progress despite the less than certain current economic environment worldwide.
WeΒ start the current year with aΒ recordΒ order bookΒ and, although historically this order book provides little longer-term visibility, it is clear that many of our customers who traditionally have much longer lead-times than ourselves are still very buoyant. Encouraged by the increasing market opportunities for the application of our technologies, we view the Company's future with confidence and optimism.
Your board proposes a final dividend ofΒ 17.63p per share, giving a total for the year ofΒ 25.39pΒ per shareΒ (2007Β 22.87p), an increase of 11%.
Sir David R McMurtry, CBE, RDI, CEng, FIMechE, FREng
Chairman & Chief Executive
23rd July 2008
Enquiries: B RΒ Taylor 01453 524445
A C G Roberts 01453 524445
Registered office: New Mills, Wotton-under-Edge, Gloucestershire. GL12 8JR
Telephone: 01453 524524
Follow the stocks